Immucell Corp (ICCC) is a publicly traded Healthcare sector company. As of May 21, 2026, ICCC trades at $9.88 with a market cap of $89.65M and a P/E ratio of -140.91. ICCC moved -4.90% today. Year to date, ICCC is +63.31%; over the trailing twelve months it is +78.34%. Its 52-week range spans $3.38 to $10.25. Rallies surfaces ICCC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Where can I find ICCC SEC filings?
Rallies organizes ICCC SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.